ESR1 and breast carcinoma: RF has been frequently used to predict the outcomes of breast cancer treatments, such as prediction of a pathological complete response after adjuvant therapy19 and risk assessment of 10-year relapse-free patients with node-negative, ER+ , and HER2- breast cancer28.